e-learning
resources
London 2016
Monday, 05.09.2016
Prognostic variables in lung cancer II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: Improving the quality of pathological diagnosis of NSCLC in England
Neal Navani (London, United Kingdom), Neal Navani, Paul Beckett, Susan Harden, Aamir Khakwani, Rosie Dickinson, Richard Hubbard, Ian Woolhouse
Source:
International Congress 2016 – Prognostic variables in lung cancer II
Session:
Prognostic variables in lung cancer II
Session type:
Thematic Poster
Number:
2879
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Neal Navani (London, United Kingdom), Neal Navani, Paul Beckett, Susan Harden, Aamir Khakwani, Rosie Dickinson, Richard Hubbard, Ian Woolhouse. LATE-BREAKING ABSTRACT: Improving the quality of pathological diagnosis of NSCLC in England. Eur Respir J 2016; 48: Suppl. 60, 2879
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
LATE-BREAKING ABSTRACT: Relationship of compliance to healthcare utilization outcomes and cost of home-telemonitoring for patients with lung cancer
Source: International Congress 2014 – From individual patient interactions to models of care: the nursing perspective
Year: 2014
Improving survival for NSCLC patients in the national lung cancer audit
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Lung cancer after lymphoma: Disease characteristics, detection methods and clinical outcome
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013
Assessment of nutritional status in patients with primary lung cancer
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Variation in lung cancer diagnosis in England
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013
Diagnosing lung cancer: Choosing the best for your patient
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Lung cancer in England: Trends in survival over the duration of the national lung cancer audit
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013
Improving NLST criteria for lung cancer screening
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Lung cancer in women: What are particularities?
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014
Nutrition and lung cancer
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016
Lung cancer, has it changed in the last ten years?
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Assessment of pain and nutritional status in patients suffering from lung cancer
Source: International Congress 2016 – Kaleidoscope of respiratory nursing
Year: 2016
Component of nursing documentation for monitoring patients suffering from lung cancer
Source: International Congress 2016 – The wide spectrum of respiratory nursing research and practice: across all ages and diseases
Year: 2016
LATE-BREAKING ABSTRACT: Clinical epidemiology of lung cancer in China: a retrospective study of 4205 patients
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014
A feasibility study: Home-telemonitoring for rural lung cancer patients
Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education
Year: 2013
Reducing the rate of emergency presentation in lung cancer
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Prognostic factors for survival in lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Defining a standard set of patient-centered outcomes for patients with lung cancer
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
LATE-BREAKING ABSTRACT: Prognostic value of microRNAs expression in stage I-IIIA lung adenocarcinoma (AC)
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013
Analysis of PET-CT use across a UK cancer network: Are we adhering to NICE guidelines?
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept